Bioventus (BVS) Divestments (2022 - 2023)
Bioventus (BVS) posted Divestments of -$11.5 million for Q2 2023, up 89.03% on a QoQ basis from -$104.8 million in Q4 2022.
Bioventus (BVS) Divestments (2022 - 2023) Analysis & Trends
Bioventus' Divestments history runs 2 years deep, the most recent figure standing at -$11.5 million for Q2 2023.
- Quarterly Divestments changed N/A year-over-year to -$11.5 million in Q2 2023, while the trailing twelve-month figure through Dec 2023 was -$11.5 million (up 89.03% YoY) and the FY2023 annual result came in at -$11.5 million, up 89.03% from the prior year.
- Divestments was -$11.5 million for Q2 2023 at Bioventus, up from -$104.8 million in the prior quarter.
- Across five years, Divestments topped out at -$11.5 million in Q2 2023 and bottomed at -$104.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 9.37 Mn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 1, 2023 | -11.51 Mn |
| Dec 31, 2022 | -104.84 Mn |